Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
2014 · New England Journal of Medicine · 1,875 citations
https://doi.org/10.1056/nejmoa1409312
D
David E. Kandzari
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
664
Papers
28.4K
Citations
82
h-index
263
i10-index
David E. Kandzari is an academic researcher from Piedmont Atlanta Hospital. The author has contributed to research in topics: Coronary Interventions and Diagnostics & Cardiac Imaging and Diagnostics & Acute Myocardial Infarction Research. The author has an h-index of 82, co-authored 565 publications.
ORCID: 0000-0002-0868-6655Papers by this author
worksEverolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
2016 · New England Journal of Medicine · 1,029 citations
https://doi.org/10.1056/nejmoa1610227
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
2020 · The Lancet · 555 citations
https://doi.org/10.1016/s0140-6736(20)30554-7
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
2019 · Circulation · 419 citations
https://doi.org/10.1161/circulationaha.119.039797
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
2020 · New England Journal of Medicine · 281 citations
https://doi.org/10.1056/nejmoa1910021
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
2022 · The Lancet · 269 citations
https://doi.org/10.1016/s0140-6736(22)00455-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat